Question 1 1 pts Studies are often done by pharmaceutical companies to determine the effectiveness of a treatment program. Suppose that a new AIDS antibody drug is currently under study. It is given to patients once the AIDS symptoms have revealed themselves. Of interest is the average (mean) length of time in months patients live once they start the treatment. A researcher followed a set of 40 patients with AIDS from the start of treatment until their deaths. The following data (in months) are collected: 3; 4; 11; 15; 16; 17; 22; 44; 37; 16; 14; 24; 25; 15; 26; 27; 33; 29; 35; 44; 13; 21; 22; 10; 12; 8; 40; 32; 26; 27; 31; 34; 29; 17; 8; 24; 18; 47; 33; 34. Select the option that best describes each of the statements below. 1. All patients with AIDS. Population V 2. The average (mean) length of time in months AIDS patients in the treatment program live once they start the treatment. Parameter V 3. The average (mean) length of time in months AIDS patients live once they start the treatment. Statistic v 4. 40 patients with AIDS in the treatment program. Sample V 5. 11; 15; 22 Data V 6. The length of time in months patients live once they start the treatment. Variable V